These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15865430)

  • 1. Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulin.
    Nunes M; Kaplan J; Wooters J; Hari M; Minnick AA; May MK; Shi C; Musto S; Beyer C; Krishnamurthy G; Qiu Y; Loganzo F; Ayral-Kaloustian S; Zask A; Greenberger LM
    Biochemistry; 2005 May; 44(18):6844-57. PubMed ID: 15865430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
    Loganzo F; Discafani CM; Annable T; Beyer C; Musto S; Hari M; Tan X; Hardy C; Hernandez R; Baxter M; Singanallore T; Khafizova G; Poruchynsky MS; Fojo T; Nieman JA; Ayral-Kaloustian S; Zask A; Andersen RJ; Greenberger LM
    Cancer Res; 2003 Apr; 63(8):1838-45. PubMed ID: 12702571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of analogues of the antimicrotubule agent N,beta,beta-trimethyl-L-phenylalanyl-N(1)-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N(1),3-dimethyl-L-valinamide (HTI-286).
    Zask A; Birnberg G; Cheung K; Kaplan J; Niu C; Norton E; Suayan R; Yamashita A; Cole D; Tang Z; Krishnamurthy G; Williamson R; Khafizova G; Musto S; Hernandez R; Annable T; Yang X; Discafani C; Beyer C; Greenberger LM; Loganzo F; Ayral-Kaloustian S
    J Med Chem; 2004 Sep; 47(19):4774-86. PubMed ID: 15341492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulin.
    Ravi M; Zask A; Rush TS
    Biochemistry; 2005 Dec; 44(48):15871-9. PubMed ID: 16313189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A; Sept D
    Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability.
    Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T
    Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical characterization of the interactions of HTI-286 with tubulin heterodimer and microtubules.
    Krishnamurthy G; Cheng W; Lo MC; Aulabaugh A; Razinkov V; Ding W; Loganzo F; Zask A; Ellestad G
    Biochemistry; 2003 Nov; 42(46):13484-95. PubMed ID: 14621994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
    Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
    Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
    Bai R; Durso NA; Sackett DL; Hamel E
    Biochemistry; 1999 Oct; 38(43):14302-10. PubMed ID: 10572005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.
    Loganzo F; Hari M; Annable T; Tan X; Morilla DB; Musto S; Zask A; Kaplan J; Minnick AA; May MK; Ayral-Kaloustian S; Poruchynsky MS; Fojo T; Greenberger LM
    Mol Cancer Ther; 2004 Oct; 3(10):1319-27. PubMed ID: 15486199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agents.
    Zask A; Kaplan J; Musto S; Loganzo F
    J Am Chem Soc; 2005 Dec; 127(50):17667-71. PubMed ID: 16351096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping surface sequences of the tubulin dimer and taxol-induced microtubules with limited proteolysis.
    de Pereda JM; Andreu JM
    Biochemistry; 1996 Nov; 35(45):14184-202. PubMed ID: 8916904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
    Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the interaction of HTI-286 with tubulin using a stilbene analogue.
    Lo MC; Aulabaugh A; Krishnamurthy G; Kaplan J; Zask A; Smith RP; Ellestad G
    J Am Chem Soc; 2004 Aug; 126(32):9898-9. PubMed ID: 15303845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin.
    Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M
    Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions.
    Bai R; Taylor GF; Schmidt JM; Williams MD; Kepler JA; Pettit GR; Hamel E
    Mol Pharmacol; 1995 May; 47(5):965-76. PubMed ID: 7746283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction.
    Bai R; Schwartz RE; Kepler JA; Pettit GR; Hamel E
    Cancer Res; 1996 Oct; 56(19):4398-406. PubMed ID: 8813133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of estramustine with tubulin isotypes.
    Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
    Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
    Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
    Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
    Zhang LH; Wu L; Raymon HK; Chen RS; Corral L; Shirley MA; Narla RK; Gamez J; Muller GW; Stirling DI; Bartlett JB; Schafer PH; Payvandi F
    Cancer Res; 2006 Jan; 66(2):951-9. PubMed ID: 16424030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.